BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 26812074)

  • 1. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis.
    Wang X; Sun W; Shen W; Xia M; Chen C; Xiang D; Ning B; Cui X; Li H; Li X; Ding J; Wang H
    J Hepatol; 2016 Jun; 64(6):1283-94. PubMed ID: 26812074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DILC suppresses cell proliferation and metastasis in colorectal cancer.
    Gu LQ; Xing XL; Cai H; Si AF; Hu XR; Ma QY; Zheng ML; Wang RY; Li HY; Zhang XP
    Gene; 2018 Aug; 666():18-26. PubMed ID: 29621586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA DILC suppresses bladder cancer cells progression.
    Ma QY; Li SY; Li XZ; Zhou TF; Zhao YF; Liu FL; Yu XN; Lin J; Chen FY; Cao J; Xi HJ; Li HY
    Gene; 2019 Aug; 710():193-201. PubMed ID: 31176734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.
    Liang C; Yang P; Han T; Wang RY; Xing XL; Si AF; Ma QY; Chen Z; Li HY; Zhang B
    Gene; 2019 Apr; 694():102-110. PubMed ID: 30716440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA DILC is involved in sepsis by modulating the signaling pathway of the interleukin‑6/signal transducer and activator of transcription 3/Toll‑like receptor 4 axis.
    Huang W; Huang L; Wen M; Fang M; Deng Y; Zeng H
    Mol Med Rep; 2018 Dec; 18(6):5775-5783. PubMed ID: 30365067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer.
    Li QG; Xu XQ; Zhou DY; Jia ZB; Yu BF; Xu FG; Zhang L
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3320-3325. PubMed ID: 31081085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lncRNA DILC attenuates neuropathic pain via the SOCS3/JAK2/STAT3 pathway.
    Liu Y; Feng L; Ren S; Zhang Y; Xue J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
    Ye C; Shen Z; Wang B; Li Y; Li T; Yang Y; Jiang K; Ye Y; Wang S
    J Exp Clin Cancer Res; 2016 Dec; 35(1):187. PubMed ID: 27912775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.
    Zhang H; Wei P; Lv W; Han X; Yang J; Qin S
    Cell Biosci; 2019; 9():81. PubMed ID: 31592114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between heat shock factor 1 and signal transducer and activator of transcription 3 mediated by interleukin-8 autocrine signaling maintains the cancer stem cell phenotype in liver cancer.
    Yang Z; Wan W; Zhang P; Wang S; Zhao Z; Xue J; Yao M; Zhao Y; Zheng W; Niu B; Wang M; Li H; Guo W; Ren Z; Hu Y
    J Gastroenterol Hepatol; 2023 Jan; 38(1):138-152. PubMed ID: 36300571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
    Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
    Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
    J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA DILC is downregulated in osteoarthritis and regulates IL-6 expression in chondrocytes.
    Huang J; Liu L; Yang J; Ding J; Xu X
    J Cell Biochem; 2019 Sep; 120(9):16019-16024. PubMed ID: 31069838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
    Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
    Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.
    Won C; Kim BH; Yi EH; Choi KJ; Kim EK; Jeong JM; Lee JH; Jang JJ; Yoon JH; Jeong WI; Park IC; Kim TW; Bae SS; Factor VM; Ma S; Thorgeirsson SS; Lee YH; Ye SK
    Hepatology; 2015 Oct; 62(4):1160-73. PubMed ID: 26154152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.
    Luo Y; Yang Z; Su L; Shan J; Xu H; Xu Y; Liu L; Zhu W; Chen X; Liu C; Chen J; Yao C; Cheng F; Zhang C; Ma Q; Shen J; Qian C
    Cancer Lett; 2016 Jun; 375(2):390-399. PubMed ID: 27000993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
    Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
    Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
    Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
    Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
    Yang Y; Chen Q; Piao HY; Wang B; Zhu GQ; Chen EB; Xiao K; Zhou ZJ; Shi GM; Shi YH; Wu WZ; Fan J; Zhou J; Dai Z
    Int J Cancer; 2020 Jan; 146(1):169-180. PubMed ID: 31090062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.